Journal
PROTEOMICS
Volume 16, Issue 5, Pages 700-714Publisher
WILEY
DOI: 10.1002/pmic.201500355
Keywords
Immonium; Localization; PTM; Signature; SUMO; Technology; Ubiquitin
Funding
- National Cancer Institute [CA184165]
- NCI's Clinical Proteomic Tumor Analysis Consortium initiative [U24CA160036]
Ask authors/readers for more resources
Mass spectrometry (MS) is a powerful tool to analyze complex mixtures of proteins in a high-throughput fashion. Proteome analysis has already become a routine task in biomedical research with the emergence of proteomics core facilities in most research institutions. Post-translational modifications (PTMs) represent a mechanism by which complex biological processes are orchestrated dynamically at the systems level. MS is rapidly becoming popular to discover new modifications and novel sites of known PTMs, revolutionizing the current understanding of diverse signaling pathways and biological processes. However, MS-based analysis of PTMs has its own caveats and pitfalls that can lead to erroneous conclusions. Here, we review the most common errors in MS-based PTM analyses with the goal of adopting strategies that maximize correct interpretation in the context of biological questions that are being addressed. Finally, we provide suggestions that should help mass spectrometrists, bioinformaticians and biologists to perform and interpret MS-based PTM analyses more accurately.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available